Compare Stocks: BBIO vs. CORT vs. AXSM vs. SMMT
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
BBIOCORTAXSMSMMT
Market Snapshot
Current market context for the selected companies.
BBIO
$81.50
Market Cap
$15.93B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
CORT
$122.25
Market Cap
$13.22B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
AXSM
$207.77
Market Cap
$10.88B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
SMMT
$13.16
Market Cap
$10.50B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-21
Performance
Absolute returns and relative performance versus SPY.
| Metric | BBIO | CORT | AXSM | SMMT |
|---|---|---|---|---|
| 1 Month | -1.7% | +26.5% | -14.0% | -12.1% |
| 1 Month vs SPY | -5.5% | +22.7% | -17.7% | -15.9% |
| 3 Months | +16.0% | +104.8% | -11.1% | -24.7% |
| 3 Months vs SPY | +12.9% | +101.7% | -14.2% | -27.8% |
| 6 Months | +19.6% | +251.1% | +13.1% | -17.4% |
| 6 Months vs SPY | +8.5% | +240.0% | +2.0% | -28.5% |
| 1 Year | +66.7% | +73.7% | +77.6% | -49.1% |
| 1 Year vs SPY | +46.7% | +53.7% | +57.6% | -69.1% |
| 2 Years | +234.0% | +259.9% | +141.1% | +13.4% |
| 2 Years vs SPY | +195.9% | +221.7% | +103.0% | -24.7% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.